Elizabeth Golden, PA
Dermatology · Indianapolis, INNPI 1184811903
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 562 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations.
Across 562 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$1K
- Pfizer$1K
- Lilly USA, LLC$872
- Sanofi$688
- Amgen$666
- plus $3K from 15 others
What the payments were for
- Consulting fees$3003%
- Food & beverage$8,71595%
- Education$1792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 101 | $1,428 |
| Novartis | 165 | $1,417 |
| Pfizer | 67 | $1,018 |
| Lilly USA, LLC | 52 | $872 |
| Sanofi | 33 | $688 |
| Amgen | 32 | $666 |
| Dermavant Sciences, Inc. | 24 | $459 |
| Regeneron Healthcare Solutions, Inc. | 11 | $374 |
| Arcutis Biotherapeutics, Inc. | 6 | $358 |
| UCB, Inc. | 17 | $309 |
| Almirall LLC | 1 | $300 |
| Johnson & Johnson | 12 | $244 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $221 |
| Boehringer Ingelheim | 6 | $183 |
| Incyte Corporation | 8 | $179 |
| Galderma Laboratories, L.p. | 6 | $170 |
| Stemline Therapeutics Inc. | 1 | $112 |
| E.r. Squibb & Sons, L.L.C. | 6 | $104 |
| Organon | 4 | $40 |
| Sun Pharmaceutical Industries Inc. | 2 | $26 |
| LEO Pharma Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,194 in reported general payments places this provider in the 75th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 32 | $119,575 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $102,879 |
| Dupixent SyringeDupilumab | 21 | $77,703 |
| Clobetasol Propionate | 92 | $4,405 |
| Tacrolimus | 25 | $3,873 |
| Ketoconazole | 167 | $2,702 |
| Fluocinonide | 63 | $2,474 |
| Fluorouracil | 35 | $2,363 |
| Doxycycline Hyclate | 80 | $1,698 |
| Clindamycin Phosphate | 33 | $1,520 |
| Metronidazole | 24 | $1,497 |
| Triamcinolone Acetonide | 181 | $1,420 |
| Fluconazole | 35 | $507 |
| ValacyclovirValacyclovir Hcl | 29 | $350 |
| Hydroxyzine Hcl | 18 | $274 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Indianapolis
- David RosmarinIndianapolis$1.1M
- Christopher ObeimeIndianapolis$907K
- Scott FretzinIndianapolis$794K
- Priya YoungIndianapolis$492K
- Nikolajs PerdueIndianapolis$302K
- Kenneth DawesIndianapolis$51K
- Annette DinneenIndianapolis$22K
- Michael IsaacsIndianapolis$14K
- Ann HyattIndianapolis$13K
- Christy NebesioIndianapolis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.